ExecPay

Nivalis Therapeutics

  • Pharmaceutical Preparations
  • Seattle, Washington

Compensation history

Top executives at Nivalis Therapeutics received an average of $1M per person in annual compensation from 2014 to 2021.

Average pay of disclosed executives at Nivalis Therapeutics

By year

Executives

We found eight executives who work or worked at Nivalis Therapeutics.

Mitchell Gold

Nivalis Therapeutics

Chief Executive Officer

6

Stanford Peng

Nivalis Therapeutics

President and Head of Research and Development

6

Paul Rickey

Nivalis Therapeutics

Chief Financial Officer

5

Zelanna Goldberg

Nivalis Therapeutics

Chief Medical Officer

1

Mark Litton

Nivalis Therapeutics

Chief Operating Officer

1

R Carruthers

Nivalis Therapeutics

Chief Financial Officer

3

Jon Congleton

Nivalis Therapeutics

Chief Executive Officer

3

Janice Troha

Nivalis Therapeutics

Chief Operating Officer

4

News

About Nivalis Therapeutics

  • Industry classifications
  • Division
    Manufacturing
    • Major group
      Chemicals And Allied Products
      • Industry group
        Drugs
        • Industry
          Pharmaceutical Preparations
  • Address
    188 East Blaine St., Suite 200, Seattle, Washington 98102
  • Phone
    206-788-4545
  • Fiscal year end
    December 31
  • Former names
  • Nivalis Therapeutics, Inc.
    Until July 24, 2017
  • N30 Pharmaceuticals, Inc.
    Until November 24, 2014
Source: SEC filings on April 29, 2022, May 5, 2020, April 24, 2019, April 24, 2018, and March 21, 2016.